维普中文期刊产品整合服务
177篇 您的检索式:作者名="Herman MP"
    题名 作者 年代 出处 被引量
1The Residual Risk Reduction Initiative:a call to action to reduce residual vascular risk in patients with dyslipidemia显示文摘Fruchart JC Sacks F Hermans MP American Journal of Cardiology0,,:2
2RhlG for the treatment of immune thrombocytopenia : consensus and controversy (CME) 显示文摘Despotovic JM Lambert MP Herman JH 2012Transfusion2012,52,5:1
3Tissue factor pathway in- hibitor - 2 is a novel inhibitor of matrix metalloproteinases with impli- cations for atherosclerosis 显示文摘Herman MP Sukhova GK Kisiel W 2001J Clin Invest2001,107,9:1
4The Residual Risk Reduction Initiative: a call to action to reduce residual vascular risk in patients with dyslipidemia 显示文摘Fruchart JC Sacks F Hermans MP 2008Am J Cardiol2008,102,10:1
5The residual risk reduction initiative:a call to action to reduce residual vascular risk in patients with dyslip idemia显示文摘Fruchart JC Sacks F Hermans MP 2008Am J Cardiol2008,102,1:1
6The Residual Risk Reduction Initiative:a call to action to reduce residual vascular risk in patients with dyslipipidemin显示文摘Fruchart JC Sacks F Hermans MP 2008Am J Cardiol2008,102,10:1
7Sleep apnoea syndrome and 10- year cardiovascular risk in females with type 2 diabetes: relationship with insulin secretion and insulin resistance显示文摘Hermans MP Ahn SA Mahadeb YP 2013Diabe- tes Metab Res Rev2013,29,3:1
8Expression of neutrophil collagenase (matrix Rnealloproteinase-8 ) in human atheroma: a novel collagenic pathway suggested by Transcriptional profiling 显示文摘Herman MP Sukhova GK Libby P 2001Circulation2001,104,16:1
9Effects of saxagliptin added to sub- maximal doses of metformin compared with uptitration of metfomain in type 2 diabetes:the PROMPT study显示文摘Hermans MP Delibasi T Farmer I 2012Curt Med Res Opin2012,28,10:1
10Public Health Interventions for Asthma显示文摘LABRE MP HERMAN E J DUMITRU GG 2012Am J Prev Med2012,42,4:1
11What is the phenotype of pa- tients with gastrointestinal intolerance tometformin 显示文摘Hermans MP Ahn SA Rousseau MF 2013Diabetes Metab2013,39,4:1
12RhIG for the treatment of immune thromboeytopenia: consensus and controversy (CME) 显示文摘DESPOTOVIC JM LAMBERT MP HERMAN JH 2012Transfusion2012,52,5:1
13The residual risk reduction initiative:A call to action to reduce residual vascular risk in dyslipidaemic patients显示文摘Fruchart JC Sacks FM Hermans MP 2008Diab Vasc Dis Res2008,5,4:1
14Frequency of glycogen storage disease type Ⅱ in the Netherlands:implications for diagnosis and genetic counseling显示文摘Ausems MG Verbiest J Hermans MP 1999Eur J Hum Genet1999,7,:1
15Statin therapy and cataract in type 2 diabetes 显示文摘Hermans MP Ahn SA Rousseau MF 2011Diabetes Metab2011,37,2:1
16Neurocognitive and functional asse ssment of patients with brain metastases:a pilot study显示文摘The outcome of patients with brain me tastases is generally poor.Surviva l alone is not necessarily a good measure of clinical outcome.Measures of neurocognitiv e function and the impact of the disease and treatments on functional status also need to be considered.Although these parameters have been measured in patients wi th primary brain tumors,they have not been as thoroughly evaluated in patients with brain metastases.The Mini-Mental State Exam ination provides limited assessmen t of neurocognitive domains impaired in brain tumor patients.It is less sensitive to mild impairment ,does not avoid memorized learning f rom repeat administration,and does not have validated alternative forms necessary for non-English speaking patients.To determine the feasibility of using a more comprehensive neurocognitive test battery,motor,verbal,executive,and daily functions were assessed in30patients with brain metastases.The test battery included the Hopkins Verbal Learning Tests,Controlled Oral Word Association T est,Grooved Pegboard Test,Trailmaking Tests A and B,and t he Barthel Index.In this study,there was complete patient compliance,w ith average test completion time of 23±6minutes.Despite high functional status,most patients demonstrated impairment in memory and fine motor domains.Neurocognitive test batte ries can and should be used in patient s with brain metastases enrolled in c linical trials.Herman MA Tremont-Lukats I Meyers CA Trask DD Froseth C Renschler MF Mehta MP 2003癌症2003,22,7:1
17Vancomycin显示文摘 Wilhelm MP 1987Mayo Clin Proc1987,62,10:1
18Early versus late parenteral nutrition in critically ill adults显示文摘Casaer MP Mesotten D Hermans G 0,,06:1
19Association between plasma triglyeerides and high-density liporotein cholesterol and microvascular kidney disease and retinopathy in type 2 diabetes mellitus: a global case-control study in 13 countries 显示文摘Sacks FM Hermans MP Fioretto P 2014Circulation2014,129,9:1
20Preoperative hydronephrosis, ureteroscopic biopsy grade and urinary cytology can improve prediction of advanced upper tract urothelial eareino ma显示文摘BRIEN JC SHARIAT SF HERMAN MP 2010J Urol2010,184,:1
返回顶部 每页显示:
共9页 首页 上一页 第1页 下一页 末页 /9 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费